Perfuze: Funding, Investors & Team (Sep 2026)
Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative catheter technology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
Perfuze has raised $49.6M across 2 funding rounds on record, the most recent an undisclosed round of $23.9M announced in Mar 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Perfuze Company Profile and Key Stats
Latest funding round on record: Mar 2025.
Perfuze Funding Rounds
Perfuze raised $25.7M in a Series A announced in Feb 2022.
3.1 years later, an undisclosed round of $23.9M was announced in Mar 2025.
Perfuze Founders and Leadership Team
Contact details for the Perfuze team: 1 of 1 has an email address on file.
Start 14-day free trial →Perfuze Funding Compared to Other Biotechnology Startups
Perfuze's latest round of $23.9M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Perfuze in Biotechnology and Newcastle
Companies Similar to Perfuze
Luminate Medical develops a medical device designed to prevent hair loss during chemotherapy. Luminate…
Antler Bio employs gene expression data to assist in herd management and provides services for analyzing…
Nemysis unique strategy is a staged approach to the development of OTC and Prescription Products, tackling…
Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation. We are…
Relevium Medical is a biopharmaceutical company with offices in both Ireland and the US that aims to enhance…
Ovagen Group Limited is a veterinary company based out of Ballina, Mayo, Ireland.
SOMAÍ is committed to building a strong global brand offering innovative cannabis-based therapeutics, aimed…
Beyondbmi offers specialized doctors and nutritionists who focus on managing weight, as well as the most…
Amara Therapeutics is passionate about empowering women and men to take control of their pelvic health. Amara…
Medical device company developing a closure device for vascular access procedures.
Carrick Therapeutics is pioneering a portfolio of unique, first in class, cancer treatments that target…
Impedans furnish you with astute detecting stages for radio-recurrence (RF) and plasma process checking.…
Perfuze Funding FAQs
What does Perfuze do?
Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative catheter technology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
How much funding has Perfuze raised?
Perfuze has raised $49.6M across 2 rounds on record. The most recent is an undisclosed round of $23.9M announced in Mar 2025.
When did Perfuze last raise funding?
Perfuze's most recent funding round on record is an undisclosed round of $23.9M, announced in Mar 2025.
Who founded Perfuze?
FundedIQ lists Wayne Allen (Founder) at Perfuze.
Where is Perfuze headquartered?
Perfuze is based in Newcastle, Galway, Ireland.
How many employees does Perfuze have?
Perfuze is in the 11-50 employee band.
How does Perfuze's funding compare to other Biotechnology startups?
Perfuze's latest round of $23.9M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Perfuze Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Perfuze is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.